1. Home
  2. Labeler Index
  3. Taro Pharmaceuticals U.s.a., Inc.
  4. 51672-4174
  5. NDC Package Code: 51672-4174-6 Imiquimod

NDC Package 51672-4174-6 Imiquimod

Cream Topical - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51672-4174-6
Package Description:
28 PACKET in 1 CARTON / .25 g in 1 PACKET (51672-4174-8)
Product Code:
51672-4174
Proprietary Name:
Imiquimod
Non-Proprietary Name:
Imiquimod
Substance Name:
Imiquimod
Usage Information:
This medication is used to treat certain types of growths on the skin. These are precancerous growths (actinic keratoses), a certain type of skin cancer (superficial basal cell carcinoma), and warts on the outside of the genitals/anus. Treating these conditions can decrease complications from them. Imiquimod belongs to a group of drugs called immune response modifiers. It is believed to work by helping to activate your immune system to fight these abnormal skin growths. This product is not recommended for use on children under 12 years of age unless specifically directed by your doctor.
11-Digit NDC Billing Format:
51672417406
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 967017 - imiquimod 3.75 % Topical Cream
  • RxCUI: 967017 - imiquimod 37.5 MG/ML Topical Cream
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Taro Pharmaceuticals U.s.a., Inc.
    Dosage Form:
    Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
    • Active Ingredient(s):
  • IMIQUIMOD 37.5 mg/g
    • Pharmacologic Class(es):
  • Increased Cytokine Activity - [PE] (Physiologic Effect)
  • Increased Cytokine Production - [PE] (Physiologic Effect)
  • Interferon Inducers - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA205971
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    01-26-2021
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    51672-4174-91 BOTTLE, PUMP in 1 CARTON / 7.5 g in 1 BOTTLE, PUMP

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51672-4174-6?

    The NDC Packaged Code 51672-4174-6 is assigned to a package of 28 packet in 1 carton / .25 g in 1 packet (51672-4174-8) of Imiquimod, a human prescription drug labeled by Taro Pharmaceuticals U.s.a., Inc.. The product's dosage form is cream and is administered via topical form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 51672-4174 included in the NDC Directory?

    Yes, Imiquimod with product code 51672-4174 is active and included in the NDC Directory. The product was first marketed by Taro Pharmaceuticals U.s.a., Inc. on January 26, 2021 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 51672-4174-6?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 51672-4174-6?

    The 11-digit format is 51672417406. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-151672-4174-65-4-251672-4174-06